Cargando…
Gene Editing with CRISPR/Cas Methodology and Thyroid Cancer: Where Are We?
SIMPLE SUMMARY: The advent of genomic editing with CRISPR/Cas9 has transformed the way we manipulate the genome, and has facilitated the investigation of tumor cell biology in vitro and in vivo. Not only we can modify genome sequence to blunt an overactivated gene or correct a mutation, but also we...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
MDPI
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8834610/ https://www.ncbi.nlm.nih.gov/pubmed/35159110 http://dx.doi.org/10.3390/cancers14030844 |